Crossref
A longitudinal study on safety and clinical efficacy of rabies biologicals for post exposure prophylaxis among the vulnerable elderly population at the anti-rabies clinic, Bangalore
APCRI Journal · 10.07.2026 · 28 (1) · 10-14
DOI: 10.24321/0973.5038.202606 ↗Kurz gefasst
Fachartikel in der Zeitschrift APCRI Journal, online erschienen am 10.07.2026. Verfasst von Ravish H S.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
S, R. H. (2026). A longitudinal study on safety and clinical efficacy of rabies biologicals for post exposure prophylaxis among the vulnerable elderly population at the anti-rabies clinic, Bangalore. APCRI Journal, 28(1), 10-14. https://doi.org/10.24321/0973.5038.202606
Vancouver
S RH. A longitudinal study on safety and clinical efficacy of rabies biologicals for post exposure prophylaxis among the vulnerable elderly population at the anti-rabies clinic, Bangalore. APCRI Journal. 2026;28(1):10-14. doi:10.24321/0973.5038.202606
BibTeX
@article{S2026,
author = {S, Ravish H},
title = {A longitudinal study on safety and clinical efficacy of rabies biologicals for post exposure prophylaxis among the vulnerable elderly population at the anti-rabies clinic, Bangalore},
journal = {APCRI Journal},
year = {2026},
volume = {28},
number = {1},
pages = {10--14},
doi = {10.24321/0973.5038.202606}
}
EUVIMED